Director/PDMR Shareholding

RNS Number : 6798A

Dechra Pharmaceuticals PLC

26 September 2022

 

26 September 2022

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 23 September 2022, it was notified that on 22 September 2022, the following PDMRs sold the shares set out below (acquired pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP) exercise/vesting announced on 22 September 2022) in order to fund the resulting tax liability. In accordance with the Company's Directors' Remuneration Policy, the remaining shares must be retained for a period of two years from the date of vesting. 

Name	Capacity	Shares Sold	Sale Price per share	Total beneficial shareholding following this announcement	Percentage of issued share capital
Ian Page	Director	10,834	£27.808	404,535	0.36%
Paul Sandland	Director	1,936	£27.808	11,714	0.01%
Tony Griffin	Director	3,608	£27.808	37,049	0.03%

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

Notification of Dealing Forms

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Partial sale of shares obtained under the Company's Long Term Incentive Plan to satisfy tax liability
c)	Price(s) and volumes(s)	Price(s) £27.807816	Volume(s) 10,834
d)	Aggregated information -  Aggregate volume -  Price -  Total	10,834 £27.807816 £301,269.88
e)	Date of the transaction	2022.09.22
f)	Place of the transaction	London Stock Exchange

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Paul Sandland
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Partial sale of shares obtained under the Company's Long Term Incentive Plan to satisfy tax liability
c)	Price(s) and volumes(s)	Price(s) £27.807816	Volume(s) 1,936
d)	Aggregated information -  Aggregate volume -  Price -  Total	1,936 £27.807816 £53,835.93
e)	Date of the transaction	2022.09.22
f)	Place of the transaction	London Stock Exchange

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Tony Griffin
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Partial sale of shares obtained under the Company's Long Term Incentive Plan to satisfy tax liability
c)	Price(s) and volumes(s)	Price(s) £27.807816	Volume(s) 3,608
d)	Aggregated information -  Aggregate volume -  Price -  Total	3,608 £27.807816 £100,330.60
e)	Date of the transaction	2022.09.22
f)	Place of the transaction	London Stock Exchange

For further information, please contact:

Melanie Hall, Company Secretary

Telephone: [phone]

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. For more information please visit: www.dechra.com .

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHBXGDCCUDDGDL